| 臺大學術典藏 |
2020-03-17T06:22:50Z |
Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests
|
Lin Y.-T.; Liu C.-M.; Chiu M.-J.; Liu C.-C.; Chien Y.-L.; Hwang T.-J.; Jaw F.-S.; Shan J.-C.; MING-HSIEN HSIEH; Hwu H.-G. |
| 臺大學術典藏 |
2020-03-17T06:22:46Z |
Facial and Prosodic Emotion Recognition Deficits Associate with Specific Clusters of Psychotic Symptoms in Schizophrenia
|
Lin Y.-T.; Hwu H.-G.; Shan J.-C.; Liu C.-C.; Tseng H.-H.; Chen S.-H.; Liu C.-M.; Howes O.; Huang Y.-L.; MING-HSIEN HSIEH |
| 臺大學術典藏 |
2020-03-17T06:22:43Z |
Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms
|
Chiou L.-C.; MING-HSIEN HSIEH; Hwu H.-G.; Lee H.-J.; Shan J.-C.; Liu C.-M.; Chien Y.-L.;Liu C.-M.;Shan J.-C.;Lee H.-J.;Ming-Hsien Hsieh;Hwu H.-G.;Chiou L.-C.; Chien Y.-L. |
| 臺大學術典藏 |
2020-03-17T06:22:43Z |
Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia - A 3-year follow-up
|
Liu C.-C.;Shan J.-C.;Chiang C.-L.;Ming-Hsien Hsieh;Liu C.-M.;Chien Y.-L.;Chen S.-C.;Hwang T.-J.; Liu C.-C.; Shan J.-C.; Chiang C.-L.; MING-HSIEN HSIEH; Liu C.-M.; Chien Y.-L.; Chen S.-C.; Hwang T.-J. |
| 臺大學術典藏 |
2020-03-04T05:35:11Z |
More evidence to support the role of S2 in P50 studies
|
Shan J.-C.; Hsieh M.H.; Liu C.-M.; MING-JANG CHIU; Jaw F.-S.; Hwu H.-G. |
| 臺大學術典藏 |
2020-03-04T05:35:05Z |
Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests
|
Lin Y.-T.; Liu C.-M.; MING-JANG CHIU; Liu C.-C.; Chien Y.-L.; Hwang T.-J.; Jaw F.-S.; Shan J.-C.; Hsieh M.H.; Hwu H.-G. |
| 臺大學術典藏 |
2020-03-04T05:35:04Z |
Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis
|
Hsieh M.H.; Shan J.-C.; Huang W.-L.; Cheng W.-C.; MING-JANG CHIU; Jaw F.-S.; Hwu H.-G.; Liu C.-C. |
| 臺大學術典藏 |
2020-03-04T05:35:03Z |
A Diagnostic Model Incorporating P50 Sensory Gating and Neuropsychological Tests for Schizophrenia
|
Shan J.-C.; Liu C.-M.; MING-JANG CHIU; Liu C.-C.; Chien Y.-L.; Hwang T.-J.; Lin Y.-T.; Hsieh M.H.; Jaw F.-S.; Hwu H.-G. |
| 臺大學術典藏 |
2020-02-26T01:33:52Z |
More evidence to support the role of S2 in P50 studies
|
Fu-Shan JawShan, J.-C.;Hsieh, M.H.;Liu, C.-M.;Chiu, M.-J.;Jaw, F.-S.;Hwu, H.-G.; Shan, J.-C.; Hsieh, M.H.; Liu, C.-M.; Chiu, M.-J.; Jaw, F.-S.; Hwu, H.-G.; FU-SHAN JAW |
| 臺大學術典藏 |
2020-02-26T01:33:52Z |
More evidence to support the role of S2 in P50 studies
|
Shan, J.-C.; Hsieh, M.H.; Liu, C.-M.; Chiu, M.-J.; Jaw, F.-S.; Hwu, H.-G.; FU-SHAN JAW |
